Blog

  • Sometimes It’s Not Peripheral Neuropathy: Carpal Tunnel, Sciatica, and Double Crush

    Not every case of numb hands or burning feet is a systemic, metabolic neuropathy. Sometimes the nerve is simply being squeezed — pinched at the wrist, compressed at the spine, or entrapped somewhere along its path. Mechanical compression is a common and often highly treatable cause of nerve symptoms, and distinguishing it from a diffuse neuropathy changes everything about the treatment. This article explains how compression injures nerves, how to recognize the pattern, and why compression and metabolic disease so often team up through a phenomenon called double crush syndrome.

    How compression injures a nerve

    A nerve under sustained mechanical pressure suffers in two main ways. First, compression restricts blood flow to the nerve (ischemia), starving it of oxygen and nutrients. Second, sustained pressure damages the nerve’s insulating myelin at the site of compression (focal demyelination), disrupting the fast, faithful conduction of signals. If the pressure continues, the underlying nerve fibers themselves can be injured. The result is numbness, tingling, pain, and sometimes weakness — but with a crucial difference from metabolic neuropathy: the problem is localized to the compressed nerve, not spread symmetrically across all the longest nerves.

    Common compression syndromes

    Carpal tunnel syndrome is the classic example: the median nerve is compressed as it passes through a tight tunnel at the wrist. It typically causes numbness and tingling in the thumb, index, middle, and part of the ring finger, often worse at night, and sometimes weakness of grip. It is one of the most common nerve disorders and is frequently very treatable.

    Radiculopathy (including sciatica) occurs when a nerve root is compressed as it exits the spine — for example, by a herniated disc or arthritic narrowing. Sciatica is the well-known form: pain, numbness, or weakness radiating from the low back down the leg along the path of the affected nerve root. Because the compression is at the spine, the symptoms follow a specific nerve’s territory rather than a stocking-glove pattern.

    Other entrapments (such as the ulnar nerve at the elbow) follow the same logic: a specific nerve, compressed at a specific spot, producing symptoms in that nerve’s specific distribution.

    Recognizing compression versus diffuse neuropathy

    The pattern is the tell. Metabolic neuropathies (like diabetic neuropathy) are usually symmetric and length-dependent — both feet first, then moving upward. Compression syndromes are usually focal and asymmetric — one nerve, one territory, sometimes provoked by particular positions or activities (typing, a night of a bent wrist, prolonged sitting). Nerve conduction studies and electromyography can localize where along a nerve the problem lies, helping confirm compression and pinpoint its site. Getting this distinction right matters, because a compressed nerve may be relieved by decompression — mechanical or surgical — whereas a metabolic neuropathy needs a metabolic approach.

    Double crush syndrome: when compression and metabolism combine

    Here is one of the most clinically important and underappreciated concepts in nerve medicine. In 1973, Upton and McComas, writing in The Lancet, proposed double crush syndrome: the idea that a nerve compressed at one point becomes more vulnerable to injury at a second point along its length. A single mild compression that might not cause symptoms on its own can become symptomatic when combined with a second insult.

    The insight extends beyond two mechanical compressions. A nerve that is metabolically stressed — by diabetes, by nutritional deficiency, by toxins — is already compromised, and that makes it far more susceptible to symptomatic injury from even modest mechanical compression. This is why so many patients have both: a metabolic neuropathy that has lowered the nerve’s reserve, plus a compression (like carpal tunnel) that pushes it over the threshold into symptoms. Treating only one of the two often leaves the patient frustrated.

    Why a dual approach works best

    The double-crush concept has a direct treatment implication: address both the mechanical and the metabolic contributors. Relieving the compression — through ergonomic changes, splinting, injections, physical therapy, or, when appropriate, decompression procedures — removes the physical insult. Simultaneously supporting the nerve’s metabolic terrain — blood sugar, nutrients, mitochondrial energy, inflammation — raises its resilience so it can tolerate normal life and heal. Neither alone fully solves a double-crush situation; together they can. This dual philosophy is exactly why a thorough evaluation checks for compression even in someone with known metabolic disease, and checks for metabolic drivers even in someone with an obvious entrapment.

    Where this fits

    Mechanical compression is the mechanical category in the three-domain framework of neuropathy drivers — and double crush syndrome is the bridge that explains why the categories so often overlap. A complete workup deliberately looks across all of them, because the most common real-world scenario is not a single cause but a combination, each amplifying the others.

    Frequently asked questions

    How do I know if it’s carpal tunnel or a general neuropathy?

    Carpal tunnel causes symptoms in a specific hand distribution, often worse at night, on one or both sides. Diffuse neuropathy is usually symmetric and starts in the feet. Nerve conduction studies can distinguish and localize the problem.

    Can I have both compression and neuropathy?

    Yes — and it’s common. Double crush syndrome describes how a metabolically stressed nerve becomes more vulnerable to compression, so the two frequently coexist and compound each other.

    Is surgery always needed for compression?

    No. Many compression syndromes respond to conservative measures — splinting, ergonomics, injections, therapy. Decompression is considered when conservative care is insufficient or damage is progressing.

    Why didn’t treating my diabetes fix my hand numbness?

    Because the hand numbness may be a compression (like carpal tunnel), not the diabetic neuropathy — a classic double-crush situation where both the mechanical and metabolic sides need attention.

    Key takeaways

    • Not all nerve pain is metabolic; mechanical compression is common and often treatable.
    • Carpal tunnel and sciatica compress a specific nerve, causing focal, asymmetric symptoms.
    • Compression injures nerves via ischemia and focal demyelination; the pattern distinguishes it from diffuse neuropathy.
    • Double crush syndrome (Upton & McComas, 1973) explains why metabolically stressed nerves are more vulnerable to compression.
    • The best results come from addressing both the mechanical and metabolic contributors together.

    Medically reviewed by Gurpreet Singh Padda, MD — Board certified in Anesthesiology, Pain Medicine, Interventional Pain Management, Addiction Medicine, and Obesity Medicine. Last reviewed July 2026.

    This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary. Take the free Nerve Damage Score or call/text (314) 886-5902.

    References

    1. Upton ARM, McComas AJ. The double crush in nerve-entrapment syndromes. Lancet. 1973;2(7825):359–362.
    2. Padua L, et al. Carpal tunnel syndrome: clinical features, diagnosis, and management. Lancet Neurol. 2016;15:1273–1284.
    3. Wilbourn AJ, Gilliatt RW. Double-crush syndrome: a critical analysis. Neurology. 1997;49:21–29.
    4. Rempel D, et al. Pathophysiology of nerve compression syndromes. J Bone Joint Surg Am. 1999.

    Find out what is driving your nerve pain

    The free, five-question Nerve Damage Score takes about two minutes and tells you which terrain failure is most likely behind your symptoms.

    Get My Free Nerve Damage Score

    Or call or text (314) 886-5902.

    Related reading

  • Mystery Neuropathy and Exhaustion? The Mold and Mycotoxin Question

    This is a topic that calls for both openness and honesty. Some patients with unexplained neuropathy paired with profound fatigue trace their symptoms to exposure in a water-damaged building, and mold and its toxins are a genuine area of scientific and clinical interest. At the same time, “mold illness” is one of the more contested subjects in medicine, prone to both dismissal on one side and overdiagnosis on the other. This article aims for the middle: what mycotoxins are, the biologically plausible ways they could affect nerves and energy, and how to approach evaluation carefully rather than credulously.

    What mycotoxins are

    Mold is a type of fungus, and some molds produce mycotoxins — toxic compounds that can contaminate the environment, particularly in water-damaged buildings where mold grows on damp materials. Mycotoxins are well established as harmful in certain contexts: contaminated food is a recognized cause of illness in humans and animals, and occupational exposures are studied. The debated question is not whether mycotoxins can be toxic — they can — but how often, and to what degree, indoor mold exposure causes the specific multi-symptom syndromes some patients and practitioners attribute to it.

    The plausible mechanisms

    The mechanisms by which mycotoxins could affect the nervous system are biologically reasonable, which is part of why the topic is taken seriously even amid the controversy.

    Mitochondrial toxicity. Some mycotoxins can impair mitochondrial function in laboratory settings. Since nerves are highly energy-dependent, anything that undermines mitochondrial energy production could, in principle, contribute to nerve dysfunction and to the profound fatigue that often accompanies these presentations — the “drained energy” theme.

    Neuroinflammation. Mycotoxins and mold exposure can provoke immune and inflammatory responses. Chronic neuroinflammation is a recognized contributor to nerve dysfunction, offering another plausible route from exposure to symptoms.

    Oxidative stress. Like other toxins, mycotoxins can increase oxidative stress and deplete antioxidant defenses, adding to the cellular strain on vulnerable tissues.

    These are mechanisms of plausibility, not proof that a given patient’s neuropathy is mold-caused — an important distinction to keep in view.

    The honest state of the evidence

    Transparency matters here. The concept of a chronic multi-system illness from indoor mold exposure (sometimes called “chronic inflammatory response syndrome”) is not universally accepted in mainstream medicine, and some of the testing and treatment marketed for it is unvalidated or commercially driven. Equally, dismissing every patient with real symptoms and a real water-damaged-building exposure does them a disservice. The defensible clinical stance is to take the exposure history and symptoms seriously, evaluate carefully with validated tools, rule in or out the well-established causes of neuropathy first, and avoid both reflexive dismissal and unproven, expensive protocols.

    A careful approach to evaluation

    For someone with unexplained neuropathy, notable fatigue, and a credible exposure to a water-damaged environment, a reasonable, non-credulous approach includes several elements. First, a thorough standard neuropathy workup to identify or exclude the common, well-established drivers — metabolic, nutritional, toxic, autoimmune, and mechanical — because these are more common and more clearly treatable, and a mold attribution should never short-circuit that search. Second, an honest environmental assessment: is there documented water damage and mold in the home or workplace? Removing or remediating a genuinely contaminated environment is sensible regardless of the diagnostic debate. Third, supporting cellular energy and reducing oxidative stress through sound, evidence-based measures — good nutrition, mitochondrial cofactors, sleep, and management of inflammation — which are low-risk and broadly beneficial. And throughout, skepticism toward unvalidated tests and proprietary “detox” protocols that promise to diagnose and cure mold illness, many of which lack rigorous support.

    Where this fits

    Mold and mycotoxins sit within the toxic category of neuropathy drivers, alongside heavy metals, medications, and alcohol. The guiding principle mirrors the heavy-metals discussion: identify and remove genuine environmental exposure, evaluate carefully, and support the body’s resilience — while keeping a clear eye on the difference between plausible mechanism and proven causation, and steering away from the unproven commercial fringe.

    Frequently asked questions

    Can mold really cause neuropathy?

    Mycotoxins are genuinely toxic and can affect mitochondria and inflammation, so a contribution is biologically plausible — but indoor-mold illness is a debated area, and other, better-established causes should be evaluated first.

    Should I get mycotoxin testing?

    Be cautious. Much of the marketed testing is unvalidated and prone to misinterpretation. Focus first on a thorough standard workup and, where relevant, a legitimate environmental assessment of the building.

    Is remediating my home worthwhile?

    If there is documented water damage and mold, addressing it is sensible for general health regardless of the diagnostic debate — removing a real exposure is low-risk and reasonable.

    What about mold “detox” protocols?

    Many are unproven and commercially driven. Prioritize evidence-based support (nutrition, sleep, mitochondrial cofactors, inflammation management) and avoid expensive, unvalidated regimens.

    Key takeaways

    • Some molds produce mycotoxins that are genuinely toxic; indoor-mold illness syndromes, however, are medically contested.
    • Plausible mechanisms include mitochondrial toxicity, neuroinflammation, and oxidative stress.
    • The evidence for chronic multi-system mold illness is not settled; avoid both dismissal and overdiagnosis.
    • Evaluate the well-established neuropathy causes first, and assess the environment realistically.
    • Be skeptical of unvalidated testing and proprietary “detox” protocols; favor low-risk, evidence-based support.

    Medically reviewed by Gurpreet Singh Padda, MD — Board certified in Anesthesiology, Pain Medicine, Interventional Pain Management, Addiction Medicine, and Obesity Medicine. Last reviewed July 2026.

    This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary. Take the free Nerve Damage Score or call/text (314) 886-5902.

    References

    1. World Health Organization. WHO Guidelines for Indoor Air Quality: Dampness and Mould. 2009.
    2. Institute of Medicine (US). Damp Indoor Spaces and Health. National Academies Press; 2004.
    3. Empting LD. Neurologic and neuropsychiatric syndrome features of mold and mycotoxin exposure. Toxicol Ind Health. 2009. (Note: represents one side of a contested literature.)
    4. Bennett JW, Klich M. Mycotoxins. Clin Microbiol Rev. 2003;16:497–516.

    Note: this topic is genuinely contested; references are provided to represent the range of evidence, and the article should retain its balanced framing.

    Find out what is driving your nerve pain

    The free, five-question Nerve Damage Score takes about two minutes and tells you which terrain failure is most likely behind your symptoms.

    Get My Free Nerve Damage Score

    Or call or text (314) 886-5902.

    Related reading

  • Neuropathy After Weight-Loss or Gallbladder Surgery? The Deficiency No One Checks

    Some neuropathies trace back to an event that happened years earlier — an operation that solved one problem while quietly setting up another. Surgeries that alter the digestive tract, including bariatric (weight-loss) procedures and gallbladder removal, can impair the absorption of nutrients the nervous system depends on. The nerve damage may appear months or years later, long after anyone is thinking about the surgery, which is exactly why the deficiency so often goes unchecked. This article explains how it happens, which nutrients are at risk, and why lifelong monitoring is the answer.

    How digestive surgery leads to nerve damage

    Nutrient absorption is a choreographed process that depends on specific parts of the digestive tract, specific stomach secretions, and — for fats and fat-soluble vitamins — bile. Surgery that changes this anatomy or physiology can disrupt absorption even when a person eats well.

    Bariatric surgery works partly by reducing how much you eat and, in some procedures, by bypassing sections of the intestine where nutrients are absorbed. It also reduces stomach acid and intrinsic factor, both needed to absorb vitamin B12. The result is a well-documented, long-term risk of multiple nutrient deficiencies.

    Gallbladder removal (cholecystectomy) changes how bile is delivered to the intestine. Because bile is essential for absorbing dietary fat and the fat-soluble vitamins (A, D, E, and K), some people develop impaired fat absorption afterward, which over time can affect nutrients like vitamin E — a deficiency specifically linked to neurological problems.

    The common thread is malabsorption: the food goes in, but the nutrients don’t fully get where they need to go.

    The nutrients at risk — and the nerves they protect

    Several deficiencies after digestive surgery are directly relevant to nerve health.

    Vitamin B12. Highly vulnerable after procedures that reduce stomach acid and intrinsic factor. B12 deficiency causes a characteristic neuropathy and can damage the spinal cord.

    Thiamine (B1). Can become deficient rapidly, especially with vomiting or poor intake after surgery, and thiamine deficiency causes neuropathy and, acutely, can precipitate the neurological emergency Wernicke’s encephalopathy. This is one to catch early.

    Copper. An underrecognized but important one. Copper deficiency — which can follow bariatric surgery (and is worsened by excessive zinc intake) — causes a myeloneuropathy, damaging both peripheral nerves and the spinal cord, sometimes mimicking B12 deficiency. It is frequently missed precisely because few clinicians think to check it.

    Fat-soluble vitamins (especially vitamin E). Impaired fat absorption, more relevant after gallbladder-related changes and malabsorptive procedures, can lead to vitamin E deficiency, which causes a distinct neurological syndrome including neuropathy and balance problems.

    Other B vitamins and minerals. Folate, B6, and others can also run low, compounding the picture.

    Why it’s so often missed

    The delay is the problem. Nutrient stores can take months or years to deplete, so the neuropathy often appears well after the surgery, by which time neither the patient nor a new clinician necessarily connects the two. Copper and vitamin E, in particular, are not on most routine panels, so they go unchecked unless someone specifically thinks of them. A patient can end up labeled with idiopathic neuropathy when the real cause is a treatable, surgery-related deficiency that simply wasn’t on anyone’s radar.

    The answer: lifelong monitoring and repletion

    The solution is straightforward in principle and requires diligence in practice. Anyone who has had bariatric surgery — and those with malabsorption after other digestive procedures — needs lifelong nutritional monitoring, including the nutrients that routine panels skip. That means periodic checks of B12 (functionally, with MMA and homocysteine), thiamine, copper, and the fat-soluble vitamins including vitamin E, along with folate and others as indicated, and repletion tailored to what testing shows.

    Repletion sometimes requires specific forms or routes (for example, higher-dose or non-oral B12) because the absorption problem that caused the deficiency also affects how supplements are absorbed. This is why post-surgical nutritional care is an ongoing medical partnership, not a one-time fix — and when a neuropathy does appear, checking this full panel can reveal a cause that is genuinely correctable.

    Where this fits

    Post-surgical malabsorption is one of the nutritional/metabolic drivers considered in a complete neuropathy workup. Its signature is the combination of an unexplained neuropathy and a history of digestive surgery — a history worth volunteering to any clinician evaluating nerve symptoms, because it points straight at a set of specific, testable deficiencies.

    Frequently asked questions

    I had weight-loss surgery years ago — could that be causing my neuropathy now?

    Yes. Deficiencies can take months to years to produce symptoms, so neuropathy appearing well after surgery is consistent with malabsorption. A targeted nutrient panel can clarify it.

    Which deficiencies get missed the most?

    Copper and vitamin E are frequently overlooked because they aren’t on standard panels, yet both cause neurological damage. B12 and thiamine also warrant checking.

    I take a multivitamin — isn’t that enough?

    Not always. Malabsorption can outpace a standard multivitamin, and some nutrients need specific forms or doses. Monitoring confirms whether your regimen is actually maintaining adequate levels.

    Does gallbladder removal cause neuropathy?

    It can contribute in some people by impairing fat and fat-soluble-vitamin absorption over time, making vitamin E deficiency worth checking when neuropathy appears.

    Key takeaways

    • Bariatric and gallbladder surgery can impair nutrient absorption and cause delayed neuropathy.
    • Key nutrients at risk: B12, thiamine, copper, and fat-soluble vitamins (especially vitamin E).
    • Copper and vitamin E deficiencies are commonly missed because they aren’t on routine panels.
    • The delay between surgery and symptoms is why the cause is so often overlooked.
    • Lifelong monitoring and tailored repletion can prevent and reverse these deficiencies.

    Medically reviewed by Gurpreet Singh Padda, MD — Board certified in Anesthesiology, Pain Medicine, Interventional Pain Management, Addiction Medicine, and Obesity Medicine. Last reviewed July 2026.

    This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary. Do not start, stop, or change supplements or medication without consulting your physician. Take the free Nerve Damage Score or call/text (314) 886-5902.

    References

    1. Kumar N. Neurologic complications of bariatric surgery. Continuum (Minneap Minn). 2014.
    2. Jaiser SR, Winston GP. Copper deficiency myelopathy and neuropathy. J Neurol. 2010;257:869–881.
    3. Becker DA, et al. Neurological complications of nutritional deficiency following bariatric surgery. J Obes. 2012.
    4. Kumar N. Nutritional neuropathies (vitamin E, B12, thiamine, copper). Neurol Clin. 2007.

    Find out what is driving your nerve pain

    The free, five-question Nerve Damage Score takes about two minutes and tells you which terrain failure is most likely behind your symptoms.

    Get My Free Nerve Damage Score

    Or call or text (314) 886-5902.

    Related reading

  • Shingles Pain That Won’t Stop? Understanding Postherpetic Neuralgia

    For most people, shingles is a miserable few weeks and then it’s over. But for a significant minority, the rash heals and the pain doesn’t — it settles into a persistent, often severe nerve pain that can last months or years. This is postherpetic neuralgia (PHN), one of the most common and most distressing forms of neuropathic pain. This article explains why a childhood chickenpox virus can come back decades later to injure nerves, what makes the pain persist, how it is treated, and how it can be prevented.

    A virus that never left

    Shingles is caused by the varicella-zoster virus (VZV) — the same virus that causes chickenpox. After a childhood chickenpox infection, the virus is not eliminated. It retreats into the dorsal root ganglia, the clusters of sensory nerve cell bodies that sit alongside the spinal cord, and lies dormant there, sometimes for decades, held in check by the immune system.

    When immunity wanes — with age, illness, stress, or immune-suppressing conditions and treatments — the virus can reactivate. It travels back down the sensory nerve to the skin, producing the characteristic painful, blistering rash of shingles in a band along the territory of that nerve. But the damage isn’t only skin-deep: the reactivation inflames and injures the nerve and its ganglion along the way.

    Why the pain persists: postherpetic neuralgia

    In postherpetic neuralgia, the nerve injury from the shingles episode leaves the affected sensory pathway damaged and dysregulated. The injured nerves become hyperexcitable and misfire, and the pain-processing system itself can become sensitized, so that even light touch on the healed skin triggers severe pain (a phenomenon called allodynia). The result is persistent burning, stabbing, or electric pain in the area where the rash was, often accompanied by exquisite sensitivity.

    Several factors raise the risk of PHN, most notably older age — the risk climbs substantially with each decade — along with greater severity of the initial shingles episode. This is why prevention and early treatment matter so much.

    Treating postherpetic neuralgia

    PHN is challenging, but there are real tools, and they work best in combination and tailored to the individual.

    Early antiviral treatment of the acute shingles episode (started promptly, within the first days of the rash) can reduce the severity and duration of the outbreak and may lower the risk of persistent pain — one reason to seek care quickly when shingles appears.

    For established PHN, treatments include topical therapies — notably the high-concentration 8% capsaicin patch, which is FDA-approved for postherpetic neuralgia and works by quieting the overactive pain fibers in the affected skin (discussed in detail in the capsaicin article), and lidocaine patches — as well as oral neuropathic-pain medications such as gabapentinoids and certain antidepressants. Because PHN is often localized, the topical, non-systemic options are especially valuable for avoiding whole-body side effects.

    Beyond symptom control, a repair-and-support philosophy addresses the injured nerve terrain itself. The video notes the use of measures aimed at supporting recovery, including cannabinoid-based therapies and glutathione. In the interest of accuracy: cannabinoids have a growing but still-evolving evidence base for neuropathic pain, and glutathione support for nerve recovery is biologically rational but not a proven cure — both belong in the category of adjuncts used within an individualized, physician-guided plan rather than established standalone treatments.

    Prevention: the most important tool

    The single most effective way to deal with postherpetic neuralgia is to prevent the shingles episode that causes it. The recombinant shingles vaccine (Shingrix) is highly effective at preventing shingles and, by extension, PHN, and is recommended for older adults and certain immunocompromised individuals. For anyone in an at-risk group who has not been vaccinated, this is a conversation worth having with a physician — preventing the outbreak is far easier than treating the pain it can leave behind.

    Where this fits

    Postherpetic neuralgia is one of the infection-related drivers of neuropathic pain. Unlike the diffuse, length-dependent neuropathies of metabolic disease, it is typically localized to the nerve territory affected by the shingles outbreak — a distinct pattern that helps identify it and shapes the localized, terrain-supportive approach to treatment.

    Frequently asked questions

    How long does postherpetic neuralgia last?

    It varies widely — from months to years. Some cases resolve gradually; others persist. Older age and a severe initial outbreak increase the likelihood of long-lasting pain.

    Can the capsaicin patch help PHN?

    Yes. The 8% capsaicin patch is FDA-approved for postherpetic neuralgia and can reduce the localized nerve pain by quieting overactive pain fibers; treatment can be repeated.

    Does treating shingles early prevent PHN?

    Prompt antiviral treatment of the acute episode can reduce its severity and may lower the risk of persistent pain, which is why fast care for a shingles rash matters.

    Can I prevent shingles altogether?

    Largely, yes. The recombinant shingles vaccine is highly effective and is recommended for older adults and some others — discuss it with your physician.

    Key takeaways

    • Shingles comes from varicella-zoster virus reactivating from the dorsal root ganglia, injuring the nerve.
    • Postherpetic neuralgia is the persistent nerve pain that can follow, driven by nerve damage and sensitization.
    • Risk rises sharply with age and with a severe initial outbreak.
    • Treatment combines topical options (including the FDA-approved 8% capsaicin patch), oral medications, and terrain support; cannabinoids and glutathione are adjuncts, not proven cures.
    • The shingles vaccine is the most effective way to prevent PHN.

    Medically reviewed by Gurpreet Singh Padda, MD — Board certified in Anesthesiology, Pain Medicine, Interventional Pain Management, Addiction Medicine, and Obesity Medicine. Last reviewed July 2026.

    This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary. Do not start, stop, or change any medication without consulting your physician. Take the free Nerve Damage Score or call/text (314) 886-5902.

    References

    1. Johnson RW, Rice ASC. Postherpetic neuralgia. N Engl J Med. 2014;371:1526–1533.
    2. Gershon AA, et al. Varicella zoster virus infection. Nat Rev Dis Primers. 2015.
    3. Backonja M, et al. NGX-4010 (capsaicin 8% patch) for postherpetic neuralgia: randomized studies. Lancet Neurol. 2008.
    4. Dooling KL, et al. Recommendations of the ACIP for use of recombinant zoster vaccine (Shingrix). MMWR. 2018.

    Find out what is driving your nerve pain

    The free, five-question Nerve Damage Score takes about two minutes and tells you which terrain failure is most likely behind your symptoms.

    Get My Free Nerve Damage Score

    Or call or text (314) 886-5902.

    Related reading

  • Alcohol and Nerve Damage: Why Your Feet Burn — and How Recovery Actually Works

    Alcohol-related nerve damage is common, often underrecognized, and — encouragingly — one of the more recoverable neuropathies when it is addressed properly. It is also a topic that deserves care and directness rather than judgment. This article explains the two distinct ways alcohol injures nerves, why the burning-feet pattern develops, and what genuine recovery requires — including an important safety note about how not to go about stopping.

    A double assault on the nerves

    Alcohol damages peripheral nerves through two mechanisms working at the same time, which is part of why the resulting neuropathy can be significant.

    Direct toxicity. Alcohol and its primary metabolite, acetaldehyde, are directly toxic to nerve tissue. Acetaldehyde is a reactive compound that damages cellular structures and proteins, and chronic exposure injures the nerve fibers themselves and the machinery that keeps them healthy. This toxic effect is thought to contribute to a length-dependent axonal neuropathy — damage that begins at the ends of the longest nerves and works inward, producing the classic burning, tingling, and numbness in the feet.

    Nutritional depletion. Heavy alcohol use depletes the body of essential nutrients, above all thiamine (vitamin B1). Alcohol interferes with thiamine absorption, storage, and activation, and heavy drinking often displaces nutritious food. Because thiamine is critical for the energy metabolism that nerves depend on, its deficiency causes neuropathy in its own right — and thiamine deficiency has other serious neurological consequences as well, including Wernicke’s encephalopathy, a medical emergency. Other B vitamins and nutrients are frequently depleted too.

    So the alcoholic neuropathy that produces burning feet is usually a combination: nerves poisoned directly and starved of the nutrients they need to function and repair.

    Why it often goes unrecognized

    Alcohol-related neuropathy can develop gradually and be attributed to aging, to diabetes (which frequently coexists), or simply dismissed. People may also be reluctant to disclose their drinking, and clinicians may not ask. The result is a treatable, partly reversible neuropathy that goes unaddressed. An honest conversation about alcohol intake is a genuinely important part of an unexplained-neuropathy workup — not to assign blame, but because it points to a cause that can be acted on.

    How recovery actually works

    The good news is that alcoholic neuropathy has real potential for improvement, because both of its drivers can be reversed. Recovery rests on three pillars.

    1. Reducing alcohol exposure. This is the foundation — the direct toxicity cannot heal while it continues. But how this is done matters enormously (see the safety note below).

    2. Repleting nutrients, especially thiamine. Restoring thiamine and other depleted B vitamins gives nerves back the cofactors they need for energy and repair. In the setting of significant deficiency or heavy use, thiamine repletion is often prioritized and, in some clinical situations, given before glucose to avoid precipitating harm — a detail that underscores why this should be medically guided.

    3. Repairing the terrain. Beyond stopping the insult and replacing nutrients, the injured nerve benefits from the same supportive measures any recovering nerve needs — attention to mitochondrial function, inflammation, and overall metabolic health. As nerve tissue repairs slowly, improvement unfolds over months.

    An important safety note

    Here is a crucial caution that a responsible article must include. For a person who is physically dependent on alcohol, stopping abruptly can be dangerous — alcohol withdrawal can cause seizures and a life-threatening condition called delirium tremens. Reducing or stopping alcohol in the setting of dependence should be done with medical support, which can make the process both safer and more successful. This is not a reason to keep drinking; it is a reason to get help doing it safely. If alcohol use is significant, the first step is a conversation with a physician about a supported plan, not going cold turkey alone.

    Help is available, and seeking it is a sign of strength, not weakness. Recovery from both the dependence and the neuropathy is genuinely possible.

    Where this fits

    Alcohol is one of the toxic drivers evaluated in a complete neuropathy assessment. It frequently overlaps with nutritional deficiency and with diabetes, so identifying it is part of assembling the full picture — and it is one of the more rewarding drivers to address, because meaningful recovery is often achievable.

    Frequently asked questions

    Can alcoholic neuropathy be reversed?

    It has real potential to improve when alcohol exposure is reduced and nutrients — especially thiamine — are replaced, though recovery is gradual and may be partial with advanced damage.

    How much alcohol causes neuropathy?

    There’s no single threshold; risk rises with the amount and duration of heavy use, and it’s compounded by poor nutrition. Coexisting diabetes lowers the margin further.

    Should I just quit cold turkey?

    If you drink heavily or are dependent, no — abrupt cessation can trigger dangerous withdrawal. Reduce or stop with medical support to do it safely.

    Which nutrient matters most?

    Thiamine (B1) is central, but other B vitamins and nutrients are commonly depleted too, so repletion is usually broader than thiamine alone.

    Key takeaways

    • Alcohol injures nerves two ways at once: direct toxicity (acetaldehyde) and thiamine/nutrient depletion.
    • The result is typically a length-dependent neuropathy with burning, tingling, and numb feet.
    • Recovery rests on reducing exposure, repleting thiamine and other nutrients, and supporting nerve repair.
    • Improvement is real but gradual; earlier action preserves more function.
    • In dependence, never stop abruptly — withdrawal can be dangerous; stop with medical support.

    Medically reviewed by Gurpreet Singh Padda, MD — Board certified in Anesthesiology, Pain Medicine, Interventional Pain Management, Addiction Medicine, and Obesity Medicine. Last reviewed July 2026.

    This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary. If you drink heavily, do not stop abruptly without medical guidance. Take the free Nerve Damage Score or call/text (314) 886-5902. If you need support for alcohol use, help is available — talk with a physician or call the SAMHSA National Helpline at 1-800-662-4357.

    References

    1. Chopra K, Tiwari V. Alcoholic neuropathy: possible mechanisms and future treatment possibilities. Br J Clin Pharmacol. 2012;73(3):348–362.
    2. Koike H, et al. Alcoholic neuropathy. Curr Opin Neurol / Muscle Nerve.
    3. Sechi G, Serra A. Wernicke’s encephalopathy: new clinical settings and recent advances. Lancet Neurol. 2007;6:442–455.

    Find out what is driving your nerve pain

    The free, five-question Nerve Damage Score takes about two minutes and tells you which terrain failure is most likely behind your symptoms.

    Get My Free Nerve Damage Score

    Or call or text (314) 886-5902.

    Related reading

  • The Cruel Irony: How Statins and Metformin Can Affect Nerve Health

    There is an uncomfortable irony at the heart of this topic: two of the most widely prescribed medications in the world — statins for cholesterol and metformin for diabetes — can, in some people, quietly deplete the very nutrients that nerves depend on. This does not mean these drugs are villains; they prevent heart attacks, strokes, and the progression of diabetes, and for most people the benefits are substantial. The point of this article is not to frighten anyone off necessary treatment, but to explain a real, manageable interaction so that the nutrients can be monitored and replaced. The answer here is repletion and monitoring, not abandoning needed medication.

    Metformin and vitamin B12

    Metformin is a cornerstone of diabetes care, and a good one. But a well-documented side effect of long-term use is impaired absorption of vitamin B12. Over years, this can produce a functional or overt B12 deficiency — and because B12 deficiency itself causes peripheral neuropathy, the result can be a patient whose diabetes drug is contributing to the very nerve symptoms being blamed entirely on their diabetes.

    This is one of the clearer, better-studied drug–nutrient interactions, and it has a clean solution: periodic monitoring of B12 status in people on long-term metformin, ideally using functional markers like methylmalonic acid and homocysteine rather than serum B12 alone (as discussed in the B12 article), and repletion when needed. Crucially, this is done without stopping metformin — the drug continues to do its job while the B12 is replaced.

    Statins and CoQ10

    Statins lower cholesterol by inhibiting an enzyme (HMG-CoA reductase) early in the cholesterol synthesis pathway. That same pathway also produces coenzyme Q10 (CoQ10), a molecule essential for mitochondrial energy production. By design, statins can therefore lower CoQ10 levels — and since nerves are metabolically demanding, the theoretical concern is that reduced CoQ10 could affect nerve energy metabolism.

    Honesty is important here, because this is a more debated area than the metformin–B12 link. The CoQ10-depletion mechanism is real. Whether statins meaningfully cause peripheral neuropathy has been studied and remains genuinely contested — some observational studies have suggested an association, while others have not confirmed a clear causal link, and any absolute risk appears small. The most defensible position is measured: statin-associated muscle symptoms are well recognized, a neuropathy association is possible but not firmly established, and the benefits of statins for cardiovascular protection are strong and well proven.

    The sensible framework: don’t stop — monitor and support

    Put together, these interactions call for a specific, non-alarmist approach.

    First, do not stop a statin or metformin on your own. Discontinuing a needed cardiovascular or diabetes medication carries real, sometimes serious, risks that typically outweigh the nutrient concerns.

    Second, monitor. In people on long-term metformin, check B12 status functionally and periodically. In people on statins with new muscle or nerve symptoms, discuss them with the prescribing clinician.

    Third, replete intelligently. Where B12 is low, replace it. Where CoQ10 supplementation is being considered for statin-related symptoms, that is a reasonable, low-risk conversation to have with a physician, recognizing that the evidence for benefit is mixed.

    Fourth, look at the whole picture. A person with diabetes on metformin and a statin may have several simultaneous contributors to their neuropathy — the diabetes itself, a metformin-related B12 deficiency, and possibly others. Sorting out how much each contributes is exactly the work of a root-cause evaluation.

    Other medications worth knowing about

    Metformin and statins are the headliners, but they are not alone. Certain chemotherapy agents are directly neurotoxic and a well-known cause of neuropathy; some antibiotics (including certain fluoroquinolones and long-term use of others) and a handful of other drugs can affect nerves as well. The recurring principle applies: the goal is informed monitoring and, where possible, mitigation — in partnership with the prescriber — rather than reflexive discontinuation.

    Frequently asked questions

    Should I stop my metformin or statin if I have neuropathy?

    No. Never stop these on your own — the risks of doing so are significant. Instead, ask your physician to check the relevant nutrient status and evaluate your symptoms.

    Does metformin definitely cause B12 deficiency?

    Long-term metformin use is a well-documented cause of impaired B12 absorption in a meaningful subset of users. It is manageable by monitoring and repletion while continuing the drug.

    Do statins cause neuropathy?

    The CoQ10-depletion mechanism is real, but whether statins meaningfully cause peripheral neuropathy is debated and any risk appears small. Muscle symptoms are the better-recognized statin side effect. Discuss new symptoms with your prescriber.

    Is it safe to take CoQ10 with a statin?

    CoQ10 is generally low-risk, and some people take it for statin-related symptoms, though the evidence for benefit is mixed. Discuss it with your physician.

    Key takeaways

    • Metformin can impair B12 absorption over time, contributing to neuropathy — a well-documented, manageable interaction.
    • Statins can lower CoQ10; a neuropathy link is possible but debated, and any risk appears small.
    • The answer is monitoring and repletion, never stopping needed medication on your own.
    • Functional B12 testing catches deficiencies a standard test misses in metformin users.
    • Multiple contributors often coexist, which is why the full picture matters.

    Medically reviewed by Gurpreet Singh Padda, MD — Board certified in Anesthesiology, Pain Medicine, Interventional Pain Management, Addiction Medicine, and Obesity Medicine. Last reviewed July 2026.

    This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary. Do not start, stop, or change any medication without consulting your physician. Take the free Nerve Damage Score or call/text (314) 886-5902.

    References

    1. Aroda VR, Edelstein SL, Goldberg RB, et al. Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab. 2016;101(4):1754–1761.
    2. Infante M, et al. Metformin, vitamin B12 deficiency and peripheral neuropathy (review). Endocrine / review.
    3. Marcoff L, Thompson PD. The role of coenzyme Q10 in statin-associated myopathy. J Am Coll Cardiol. 2007;49:2231–2237.
    4. Emad M, et al. Statins and peripheral neuropathy — evidence and controversy (review).

    Find out what is driving your nerve pain

    The free, five-question Nerve Damage Score takes about two minutes and tells you which terrain failure is most likely behind your symptoms.

    Get My Free Nerve Damage Score

    Or call or text (314) 886-5902.

    Related reading

  • The Slow Poison in Your Bloodstream: How Heavy Metals Damage Your Nervous System

    Some causes of neuropathy announce themselves. Heavy-metal toxicity does the opposite: it accumulates quietly, often over years, from sources a person may never connect to their symptoms — old plumbing, contaminated water, certain occupations, some imported products. By the time nerve damage appears, the exposure may be long-standing. This article explains how metals like lead, arsenic, and mercury injure the nervous system, when to suspect them, and — just as importantly — why the popular world of aggressive “detox” can do more harm than the metals themselves.

    Why metals are so toxic to nerves

    Heavy metals damage nerves through a few overlapping mechanisms. They disrupt essential enzymes by binding to sulfur-containing sites the enzymes need to function, effectively jamming the machinery of the cell. They deplete glutathione, the body’s master antioxidant, leaving nerves defenseless against oxidative stress. And they interfere with mitochondrial energy production, starving the energy-hungry nerve of the fuel it needs. The nervous system, with its high metabolic demand and long, vulnerable fibers, is among the tissues most sensitive to these insults.

    The main offenders

    Lead. A classic cause of peripheral neuropathy, historically associated with a motor-predominant pattern (weakness, sometimes wrist drop). Exposure can come from old lead paint and pipes, certain occupations (battery work, smelting, construction, radiator repair), contaminated soil, and some traditional remedies and imported goods.

    Arsenic. Causes a painful sensory neuropathy that can resemble other length-dependent neuropathies, often with characteristic skin changes. Exposure sources include contaminated groundwater (a significant issue in some regions), certain pesticides, and industrial processes.

    Mercury. Affects both the peripheral nerves and the central nervous system. Sources include certain fish (methylmercury), some industrial exposures, and older dental or medical materials.

    Thallium and others. Less common but notable causes of severe neuropathy, sometimes with hair loss as a clue.

    When to suspect metal toxicity

    Heavy-metal neuropathy is worth considering when there is a plausible exposure history — an occupation, hobby, water source, or product that could carry the metal — particularly when the neuropathy is otherwise unexplained, is progressing, or is accompanied by systemic clues (abdominal symptoms, anemia, skin or nail changes, cognitive complaints). The history is the single most important guide; without a reason to suspect exposure, indiscriminate testing tends to generate more confusion than clarity.

    Testing done right

    When exposure is plausible, testing should be targeted and appropriate to the specific metal. Different metals require different specimens and timing — for instance, some are best assessed in blood for recent exposure and others in urine or with provoked testing under careful supervision. This is a domain where testing should be interpreted by a clinician familiar with toxicology, because reference ranges, specimen types, and the meaning of results all depend on the metal and the exposure timeline.

    The detox trap

    Here is the part that deserves a blunt warning. The internet is full of “heavy-metal detox” protocols — supplements, cleanses, and chelation regimens marketed for everything from fatigue to neuropathy. Many are unproven, some are useless, and a few are genuinely dangerous. Aggressive or improperly supervised chelation can redistribute metals to sensitive tissues, cause serious electrolyte and kidney problems, and has been linked to harm. Chelation therapy has legitimate, specific medical indications for confirmed significant toxicity — but it is a medical treatment with real risks, not a wellness product, and it should only ever be done under qualified medical supervision after appropriate testing confirms a treatable burden.

    The responsible approach is the opposite of a generic cleanse: identify and remove the source of exposure, confirm the specific metal with proper testing, support the body’s own detoxification pathways (including glutathione status) sensibly, and reserve chelation for the specific, confirmed situations where medical evidence supports it.

    Where this fits in the bigger picture

    Heavy metals are one of the toxic drivers evaluated in a complete root-cause neuropathy workup, alongside medications, alcohol, and mold. As with the others, the value of identifying a metal contribution is that removing the exposure can halt ongoing damage — but it has to be identified correctly first, which is why history-guided, targeted evaluation matters so much here.

    Frequently asked questions

    Could heavy metals be causing my neuropathy without my knowing?

    It’s possible if you have a genuine exposure source. Because accumulation is slow and silent, the link is easy to miss — which is why exposure history is key.

    Should I get a heavy-metal panel just to check?

    Testing is most useful when guided by a plausible exposure. Untargeted “panels,” especially provoked urine tests marketed online, are prone to misinterpretation. Discuss appropriate testing with a clinician.

    Are detox supplements or cleanses a good idea?

    Generally no. Many are unproven, and aggressive chelation carries real risks. Legitimate treatment for confirmed toxicity is a supervised medical process, not a store-bought cleanse.

    What’s the most important first step?

    Finding and removing the source of exposure. No treatment works while exposure continues.

    Key takeaways

    • Heavy metals injure nerves by disrupting enzymes, depleting glutathione, and impairing mitochondria.
    • Lead, arsenic, and mercury are the main offenders, each with characteristic patterns and sources.
    • Suspicion should be driven by a real exposure history; testing must be targeted and expertly interpreted.
    • Removing the source is the essential first step.
    • Unproven “detox” and unsupervised chelation can be harmful; chelation is a supervised medical treatment for confirmed toxicity only.

    Medically reviewed by Gurpreet Singh Padda, MD — Board certified in Anesthesiology, Pain Medicine, Interventional Pain Management, Addiction Medicine, and Obesity Medicine. Last reviewed July 2026.

    This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary. Do not attempt detoxification or chelation without qualified medical supervision. Take the free Nerve Damage Score or call/text (314) 886-5902.

    References

    1. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profiles: Lead, Arsenic, Mercury.
    2. Thomson RM, Parry GJ. Neuropathies associated with excessive exposure to lead. Muscle Nerve. 2006.
    3. Rao DG, et al. Arsenic-induced peripheral neuropathy. Pract Neurol / review.
    4. Kern JK, et al. Cautions regarding chelation and unproven detoxification; glutathione and heavy-metal toxicity (review).

    Find out what is driving your nerve pain

    The free, five-question Nerve Damage Score takes about two minutes and tells you which terrain failure is most likely behind your symptoms.

    Get My Free Nerve Damage Score

    Or call or text (314) 886-5902.

    Related reading

  • Caught in the Crossfire: How Lupus and Rheumatoid Arthritis Attack Your Nerves

    When the immune system is dysregulated, nerves are rarely the intended target — but they are frequently the casualties. Autoimmune diseases such as lupus, rheumatoid arthritis, and Sjögren’s syndrome can produce peripheral neuropathy as collateral damage from a body-wide inflammatory process. This article explains the two main routes by which autoimmunity injures nerves, why the resulting neuropathy can take several distinct forms, and why effective treatment must address both the systemic disease and the nerve.

    Nerves as collateral damage

    In an autoimmune disease, the immune system loses the ability to distinguish self from non-self and begins attacking the body’s own tissues. In lupus (systemic lupus erythematosus) and rheumatoid arthritis, the headline targets are joints, skin, kidneys, and other organs — but the same inflammatory machinery can reach the peripheral nerves. Understanding neuropathy in this setting means understanding that the nerve damage is a downstream consequence of a systemic process, which is why simply treating the nerve is not enough.

    Route one: vasculitis — choking the nerve’s blood supply

    Peripheral nerves depend on a network of tiny blood vessels, the vasa nervorum, for their oxygen and nutrients. In autoimmune disease, these vessels can become inflamed — a process called vasculitis. Inflammation thickens and occludes the vessel walls, cutting off blood flow and starving segments of nerve of oxygen (ischemia). The nerve tissue downstream is injured or dies.

    Vasculitic neuropathy often produces a distinctive pattern called mononeuritis multiplex, in which several individual nerves are damaged in a patchy, asymmetric fashion — for example, a wrist drop on one side and a foot drop on the other, rather than the symmetric stocking-glove pattern typical of diabetic neuropathy. This asymmetry is an important clue that points toward a vasculitic, autoimmune cause. Vasculitic neuropathy can progress quickly and is considered a situation that warrants prompt evaluation.

    Route two: direct antibody attack

    The second route is more direct. The autoantibodies and immune complexes generated in autoimmune disease can bind to and attack nerve components themselves, including the myelin sheath and the nerve fibers. Sjögren’s syndrome is particularly associated with sensory neuropathies — including a sensory ganglionopathy in which the sensory nerve cell bodies themselves are targeted — which can cause numbness, imbalance, and painful burning sensations. Different autoimmune conditions favor different antibody targets, which is part of why autoimmune neuropathy is not a single entity but a family of presentations.

    Recognizing the pattern

    Several features raise suspicion that a neuropathy is autoimmune in origin: an asymmetric or patchy distribution (mononeuritis multiplex), a relatively rapid onset, the presence of systemic symptoms (joint pain, rash, dry eyes and mouth, fatigue), and a known or suspected autoimmune diagnosis. When these are present, the workup expands to include autoimmune serologies and, in some cases, nerve conduction studies or nerve biopsy to characterize the process.

    Why treatment must be two-pronged

    This is the central clinical message. Because the neuropathy is driven by a systemic autoimmune process, controlling that process is essential — typically the domain of rheumatologic care, using immune-modulating treatment to quiet the underlying disease. But calming the systemic inflammation does not automatically repair nerves that have already been injured. The nerve itself also needs support: pain management, protection of remaining function, and attention to the same terrain factors — circulation, nutrients, mitochondrial energy — that any injured nerve requires to recover.

    A terrain-focused clinic works alongside a patient’s rheumatologist rather than in place of them: the rheumatologist targets the fire, and the nerve-focused care supports the tissue caught in it. Neither alone is sufficient.

    The overlap with other drivers

    Autoimmune disease also raises the stakes on other neuropathy drivers. Systemic inflammation, certain immune-modulating medications, and reduced activity can all compound nutritional and metabolic contributors, so a complete evaluation still checks the full range of causes rather than stopping at the autoimmune label.

    Frequently asked questions

    How is autoimmune neuropathy different from diabetic neuropathy?

    Diabetic neuropathy is usually symmetric and starts in the feet. Autoimmune neuropathy is often asymmetric and patchy (mononeuritis multiplex) and tends to accompany other systemic symptoms.

    If I control my lupus or RA, will my neuropathy go away?

    Controlling the underlying disease is essential to stop ongoing damage, but nerves already injured need separate support and recover slowly. The two goals go together.

    Can neuropathy be the first sign of an autoimmune disease?

    Sometimes. An unexplained, especially asymmetric, neuropathy can prompt discovery of an underlying autoimmune condition, which is why the workup includes autoimmune testing.

    Should I stop my immune medications if I develop neuropathy?

    No — never adjust these on your own. Some are treating the very process damaging your nerves. Any change is made with your rheumatologist and physician.

    Key takeaways

    • Lupus, RA, and Sjögren’s can damage nerves as collateral damage from systemic autoimmunity.
    • Vasculitis starves nerves of blood, often causing asymmetric mononeuritis multiplex.
    • Direct antibody attack targets myelin and nerve fibers; Sjögren’s favors sensory neuropathies.
    • Asymmetry, rapid onset, and systemic symptoms are clues to an autoimmune cause.
    • Treatment must control the systemic disease and support the injured nerve.

    Medically reviewed by Gurpreet Singh Padda, MD — Board certified in Anesthesiology, Pain Medicine, Interventional Pain Management, Addiction Medicine, and Obesity Medicine. Last reviewed July 2026.

    This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary. Do not start, stop, or change any medication without consulting your physician. Take the free Nerve Damage Score or call/text (314) 886-5902.

    References

    1. Collins MP, Hadden RD. The nonsystemic vasculitic neuropathies. Nat Rev Neurol. 2017;13:302–316.
    2. Mori K, et al. The wide spectrum of clinical manifestations in Sjögren’s syndrome–associated neuropathy. Brain. 2005;128:2518–2534.
    3. Oomatia A, et al. Peripheral neuropathies in systemic lupus erythematosus. Arthritis Rheumatol. 2014.
    4. Gwathmey KG, et al. Vasculitic neuropathies. Lancet Neurol. 2014;13:67–82.

    Find out what is driving your nerve pain

    The free, five-question Nerve Damage Score takes about two minutes and tells you which terrain failure is most likely behind your symptoms.

    Get My Free Nerve Damage Score

    Or call or text (314) 886-5902.

    Related reading

  • Negative Celiac Test but Burning Feet? The Gluten–Neuropathy Link Doctors Miss

    You did the responsible thing. You mentioned your burning feet, someone ordered a celiac panel, it came back negative, and gluten was crossed off the list. But for a large number of people with gluten-related nerve damage, that negative result is exactly where the diagnosis goes wrong. The celiac test is answering a different question than the one your nerves are asking. This article explains why standard celiac screening misses gluten neuropathy, and what testing actually reveals it.

    The celiac test answers the wrong question

    Celiac disease is defined by an immune attack on the small intestine. Its screening tools are built to detect that — chiefly antibodies to tissue transglutaminase-2 (tTG-2), the transglutaminase isoform concentrated in the gut, confirmed by intestinal biopsy showing damage to the villi.

    Gluten-related neurological disease is a different manifestation of gluten sensitivity. The immune response targets the nervous system, and the gut may be entirely spared. A patient can therefore have a pristine celiac panel and normal intestinal biopsy while producing the antibodies that are injuring their peripheral nerves. The test isn’t broken — it’s simply looking in the wrong place.

    What the immune system actually targets in the nerves

    As covered in the companion article on the gluten–neuropathy connection, the mechanism is molecular mimicry. Two targets are especially relevant to a nerve-focused workup.

    Transglutaminase-6 (TG6). This isoform is expressed in nervous tissue, and antibodies against it — described by Dr. Marios Hadjivassiliou’s group — mark the neurological form of gluten sensitivity. TG6 antibodies can be present when the gut-focused tTG-2 antibodies are absent, which is precisely why a celiac screen can miss neurological disease.

    Anti-myelin and related antibodies. The immune response can also target components of the myelin sheath that insulates nerves, contributing to the sensory neuropathy and, when the cerebellum is involved, the ataxia seen in gluten-related neurological disease.

    The genetics: HLA-DQ2 and HLA-DQ8

    Gluten sensitivity has a strong genetic underpinning. The great majority of people who react to gluten — whether the celiac or the neurological form — carry one of two immune-system genetic markers, HLA-DQ2 or HLA-DQ8. Testing for these haplotypes is informative in a different way than antibody testing: a negative HLA-DQ2/DQ8 result makes gluten-driven disease very unlikely and can effectively rule it out, while a positive result establishes susceptibility (though not everyone who is susceptible develops disease). This makes HLA typing a useful gatekeeping test in an unexplained neuropathy workup.

    Building a proper gluten-neuropathy panel

    For someone with an unexplained sensory neuropathy — especially with any balance disturbance — a more complete evaluation than a routine celiac screen includes HLA-DQ2/DQ8 genetic typing, an expanded gluten-related antibody panel (including TG6 where available, alongside the conventional celiac antibodies), and a clinical assessment for the length-dependent sensory pattern and any cerebellar signs. The aim is to catch the neurological form that the standard screen is not designed to see.

    An important practical caveat: antibody testing is most meaningful while gluten is still in the diet. If a patient has already gone gluten-free, antibody levels may fall and produce falsely reassuring results — something to plan around with a clinician before testing.

    Why it’s worth the effort

    Chasing down a gluten contribution is worthwhile because, unlike many drivers of neuropathy, it is entirely removable — the trigger is dietary. When gluten-related neurological disease is confirmed and strict elimination is undertaken early, symptoms can stabilize and sometimes improve. The tragedy of the missed diagnosis is that the person keeps eating the trigger for years, attributing their progressive nerve damage to bad luck or aging, when a change on the plate could have changed the trajectory.

    This is one driver among several

    Gluten sensitivity is one possible contributor evaluated within a broader root-cause investigation that also weighs metabolic, toxic, and mechanical causes. Because multiple drivers frequently coexist, ruling gluten in or out is part of assembling the complete picture rather than a search for a single culprit.

    Frequently asked questions

    My celiac test was negative — can gluten still be damaging my nerves?

    Yes. Celiac screening detects the intestinal form of gluten disease. The neurological form can occur with a negative celiac panel and normal gut biopsy, driven by antibodies like TG6.

    What should I ask to be tested for instead?

    Consider HLA-DQ2/DQ8 genetic typing and an expanded gluten-related antibody panel including transglutaminase-6 where available, ideally while still eating gluten.

    If I already went gluten-free, will testing still work?

    Antibody levels can fall after gluten removal, which may make results falsely negative. Discuss timing with your physician before testing.

    Does a positive HLA-DQ2/DQ8 mean I definitely have gluten neuropathy?

    No — it establishes susceptibility, not disease. It’s most useful in the reverse: a negative result makes gluten-driven disease very unlikely.

    Key takeaways

    • Standard celiac tests detect intestinal disease, not the neurological form of gluten sensitivity.
    • Transglutaminase-6 (TG6) antibodies mark the neural attack and can be present with a negative celiac panel.
    • HLA-DQ2/DQ8 typing is a useful gatekeeper: a negative result largely rules gluten out.
    • Test while still eating gluten, since prior elimination can produce falsely negative antibodies.
    • Confirmed gluten neuropathy is uniquely treatable, because the trigger is removable.

    Medically reviewed by Gurpreet Singh Padda, MD — Board certified in Anesthesiology, Pain Medicine, Interventional Pain Management, Addiction Medicine, and Obesity Medicine. Last reviewed July 2026.

    This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary. Do not make major dietary or medication changes without consulting your physician. Take the free Nerve Damage Score or call/text (314) 886-5902.

    References

    1. Hadjivassiliou M, et al. Transglutaminase-6 antibodies in the diagnosis of gluten ataxia. Neurology. 2013;80:1740–1745.
    2. Hadjivassiliou M, Sanders DS, Grünewald RA, et al. Gluten sensitivity: from gut to brain. Lancet Neurol. 2010;9:318–330.
    3. Hadjivassiliou M, et al. Gluten-related neurological dysfunction and HLA associations.
    4. Volta U, et al. Serological tests in gluten-related disorders. Cell Mol Immunol / review.

    Find out what is driving your nerve pain

    The free, five-question Nerve Damage Score takes about two minutes and tells you which terrain failure is most likely behind your symptoms.

    Get My Free Nerve Damage Score

    Or call or text (314) 886-5902.

    Related reading

  • Your “Normal” B12 May Be Lying: The Hidden Deficiency Driving Your Neuropathy

    One of the most treatable causes of peripheral neuropathy is also one of the most frequently missed — not because doctors don’t test for it, but because the usual test can read “normal” while the deficiency is doing real damage at the cellular level. This article explains why a serum B12 result can be misleading, which functional markers reveal what it hides, and the full roster of nutrients your nerves depend on to function and to heal.

    Why a “normal” B12 can be wrong

    The standard test measures the total amount of vitamin B12 circulating in your blood. The problem is that this number does not necessarily reflect how much B12 is actually available and working inside your cells. A substantial portion of measured B12 is bound to a protein that cannot deliver it to tissues, so the total can look adequate while the metabolically active supply is low. Reference ranges also vary, and results in the low-normal zone are commonly reported as fine even when a patient is symptomatic.

    The consequence is a patient with the classic tingling, numbness, and imbalance of a B12-related neuropathy being told their levels are “normal,” while the underlying deficiency quietly progresses. Untreated, B12 deficiency can damage not only peripheral nerves but the spinal cord itself — and while early damage is reversible, advanced damage may not be.

    The functional markers that tell the truth: MMA and homocysteine

    To see what serum B12 hides, clinicians use functional markers — substances that accumulate when B12 is inadequate at the cellular level, regardless of what the total blood level says.

    Methylmalonic acid (MMA). B12 is a required cofactor for the enzyme that processes methylmalonyl-CoA. When B12 is functionally deficient inside cells, this reaction stalls and MMA builds up. An elevated MMA is a sensitive and relatively specific sign of true B12 deficiency at the tissue level.

    Homocysteine. B12 (along with folate and B6) is needed to convert homocysteine into methionine. When B12 is functionally low, homocysteine rises. Elevated homocysteine is less specific than MMA — it can also reflect folate or B6 deficiency — but together the two markers give a far more accurate picture than serum B12 alone.

    Checking MMA and homocysteine can catch a functional deficiency that a normal B12 would have masked, allowing correction before permanent nerve or spinal-cord injury occurs.

    Common reasons B12 runs low

    Functional B12 deficiency is especially worth checking in several situations. Metformin, one of the most-prescribed diabetes medications, interferes with B12 absorption and can produce deficiency over years of use — a cruel irony in patients whose diabetes is already threatening their nerves. Acid-suppressing drugs (PPIs and H2 blockers) reduce the stomach acid needed to liberate B12 from food. Age reduces absorption, as can autoimmune (pernicious) causes, gastrointestinal surgery, and strict plant-based diets. Anyone with unexplained neuropathy and any of these risk factors deserves functional testing.

    B12 is not alone: the nutrient team your nerves need

    B12 gets the headlines, but nerves depend on a whole team of cofactors, and deficiency of any one can impair function or healing.

    Thiamine (B1). Essential for glucose metabolism and mitochondrial energy production. Thiamine deficiency directly causes neuropathy, and it is often depleted in diabetes and in heavy alcohol use. The work of Dr. Hammes and colleagues highlighted how thiamine-dependent pathways protect against the biochemical damage of high blood sugar — part of the rationale for the thiamine derivative benfotiamine.

    Vitamin B6. Required for nerve function and neurotransmitter synthesis — but with an important caveat: both deficiency and excess can cause neuropathy, so B6 supplementation should be measured and monitored, not open-ended.

    Magnesium. A cofactor in hundreds of enzymatic reactions, including those governing nerve excitability and mitochondrial energy. Deficiency contributes to nerve hyperexcitability and is common in diabetes.

    Omega-3 fatty acids. Structural components of nerve membranes with anti-inflammatory effects; adequate intake supports the membrane integrity and the inflammatory balance that healthy nerves require.

    The mitochondrial common thread

    Notice the recurring theme: nearly every one of these nutrients feeds into mitochondrial energy production. A nerve is an energy-intensive structure, and it fails when its power supply falters. This is why correcting deficiencies is not simply “topping up vitamins” — it is restoring the cell’s ability to make energy, repair itself, and maintain its signaling. Functional nutrient testing, and correction guided by that testing, is a foundational part of a root-cause neuropathy plan rather than an afterthought.

    What to do with this information

    The practical message is to test properly and correct precisely. That means functional markers (MMA, homocysteine) rather than serum B12 alone, evaluation of thiamine and magnesium status, a review of medications that deplete these nutrients (without stopping needed prescriptions on your own), and repletion tailored to what the testing shows. Because some deficiencies (like B6) can harm in excess, and because absorption problems may require specific forms or routes of supplementation, this is best done under medical guidance.

    Frequently asked questions

    My B12 came back normal — could it still be my problem?

    Yes. Total serum B12 can read normal while the active, cellular supply is low. MMA and homocysteine testing can reveal a functional deficiency the standard test misses.

    Does metformin cause B12 deficiency?

    It can, over time, by impairing absorption. If you take metformin and have neuropathy symptoms, functional B12 testing is reasonable — but do not stop metformin on your own.

    Can I just take high-dose B vitamins to be safe?

    Not blindly. B6 in particular can cause neuropathy in excess, and effective correction depends on which nutrient is actually deficient and how well you absorb it. Test, then treat.

    How quickly does nerve function recover after correction?

    Early deficiency-related damage often improves once corrected, but recovery is gradual and advanced damage may be incomplete. Earlier detection means better outcomes.

    Key takeaways

    • A “normal” serum B12 can hide a cellular deficiency that damages nerves and even the spinal cord.
    • Functional markers — methylmalonic acid and homocysteine — reveal true tissue-level deficiency.
    • Metformin, acid-suppressing drugs, age, and GI issues are common causes worth screening for.
    • Nerves also depend on thiamine, B6 (in balance), magnesium, and omega-3s, mostly via mitochondrial energy.
    • Test functionally and correct precisely, under guidance — don’t self-dose blindly.

    Medically reviewed by Gurpreet Singh Padda, MD — Board certified in Anesthesiology, Pain Medicine, Interventional Pain Management, Addiction Medicine, and Obesity Medicine. Last reviewed July 2026.

    This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary. Do not start, stop, or change any medication or supplement without consulting your physician. Take the free Nerve Damage Score or call/text (314) 886-5902.

    References

    1. Stabler SP. Vitamin B12 deficiency. N Engl J Med. 2013;368:149–160.
    2. Aroda VR, et al. Long-term metformin use and vitamin B12 deficiency (Diabetes Prevention Program Outcomes Study). J Clin Endocrinol Metab. 2016.
    3. Hammes HP, et al. Benfotiamine blocks three major pathways of hyperglycemic damage. Nat Med. 2003;9:294–299.
    4. Ghavanini AA, Kimpinski K. Revisiting the evidence for neuropathy caused by pyridoxine (B6) deficiency and excess. J Clin Neuromuscul Dis. 2014.

    Find out what is driving your nerve pain

    The free, five-question Nerve Damage Score takes about two minutes and tells you which terrain failure is most likely behind your symptoms.

    Get My Free Nerve Damage Score

    Or call or text (314) 886-5902.

    Related reading